The Digital Content Revolution of the Pharmaceutical Industry

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Subsection - Oncology

Essential DMPK Strategies for IND Success

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

The digital transformation of the pharmaceutical industry has been slow and is far from complete. This unique transformation started with basic video content in the early 90s to the different
forms of reality such as augmented, virtual and now mixed. Ben Ramsbottom at Random42 Scientific Communication discusses how this was the first and now the biggest provider of medical
animation for the pharma sector, as well all the other digital services that enable healthcare professionals (HCPs), patients and investors to visualise the biological process.

[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2019/11/The-Digital-Content-Revolution-of-the-Pharmaceutical.pdf” width=”100%” height=”900px” style=”border:0;”]